Trials / Unknown
UnknownNCT00189657
5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Association Européenne de Recherche en Oncologie · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The main objective of this randomized trial is to compare 5FU/LV (Mayo-Clinic regimen or LV5FU2) to LV5FU2 + irinotécan in patients with resected B2 and C rectal cancer. Preoperative radiotherapy is recommended but not mandatory. Main endpoint is disease free survival. Secondary endpoint are overall survival, time to local recurrence, time to distant metastases, and tolerance. A total of 600 patients will be included in the trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | 5FU/LV Mayo Clinic or LV5FU2 | |
| PROCEDURE | LV5FU2 + irinotecan |
Timeline
- First posted
- 2005-09-19
- Last updated
- 2005-09-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00189657. Inclusion in this directory is not an endorsement.